Table 1.
Clinical and demographic data of the studied population.
| Variable | |
|---|---|
| N | 151 |
| Age (years) | 33.4 ± 13 |
| Gender, female (%) | 81 (53.6) |
| Ethnicity, Caucasian (%) | 69 (45.7) |
| Age at diagnosis (years) | 17.2 ± 9.8 |
| Diabetes duration (years) | 16.3 ± 9.5 |
| BMI (Kg/m2) | 23.4 (13.7–37.9) |
| Abdominal circumference (cm) | 79.8 ± 9.8 |
| Hypertension, n (%) | 36 (23.8) |
| Current smoker, n (%) | 11 (7.3) |
| sBP (mmHg) | 124.6 ± 16.6 |
| dBP (mmHg) | 75.1 ± 10.4 |
| Heart rate (bpm) | 79 (50–134) |
| HbA1c (%) | 9.1 ± 2 |
| Fasting glycemia (mg/dl) | 170 (21–561) |
| Postprandial glycemia | 223 ± 95 |
| Total cholesterol (mg/dl) | 176 (98–330) |
| Triglycerides (mg/dl) | 79 (32–748) |
| HDL-c (mg/dl) | 62.9 (32.7–165.8) |
| LDL-c (mg/dl) | 94 ± 27.4 |
| Lipid-lowering mediations, n (%) | 49 (32.5) |
| BP-lowering medications, n (%) | 55 (33.8) |
| Diabetic retinopathy, n (%) | 55 (37.7) |
| Normoalbuminuria/microalbuminuria) macroalbuminuria, n (%) | 110 (75.9)/32 (23.4)/1 (0.7) |
| Diabetic neuropathy, n (%) | 44 (29.1) |
The data are presented as counts (percentage), means ± SD, or medians (minimum/maximum).
BMI, body mass index; sBP, systolic blood pressure; dBP, diastolic blood pressure; BP, blood pressure; GFR, glomerular filtration rate.